Novo Nordisk A/S (NOVO-B.CO) Diversifiers

Equity · Currency in DKK · Last updated Jun 5, 2026

Novo Nordisk A/S engages in the research, development, manufacture, and distribution of pharmaceutical products, primarily focusing on diabetes and obesity care, as well as rare diseases. The company also provides innovative treatment solutions, including smart insulin pens and applications for insulin dose guidance.

Looking to balance out your exposure to NOVO-B.CO? The ETFs below have the lowest correlation with NOVO-B.CO — they tend to move on their own, which can help reduce risk when NOVO-B.CO drops. The stock ideas table highlights individual companies that behave independently from NOVO-B.CO.

No Diversifiers Found for NOVO-B.CO

We do not have enough correlation history to rank diversifiers for this symbol yet.

Diversification Analysis

Build a portfolio that complements NOVO-B.CO

Add NOVO-B.CO to the Diversification Analyzer to see how it overlaps with your other holdings and which assets balance it best.

Analyze a portfolio with NOVO-B.CO